INS and metabolic syndrome: In a randomized crossover study, the fecal concentrations of both isobutyrate and isovalerate were significantly decreased in subjects with metabolic syndrome, including dyslipidemia, insulin sensitivity, and abdominal obesity, in response to dietary fiber intervention [44], indicating that increased cholesterol levels may be linked to elevated isobutyrate and isovalerate.